Bioactivity‐based molecular networking guided identification of guttiferone J from Garcinia cambogia as an anti‐obesity candidate

Zheling Feng,Jiali Chen,Cheng Chen,Lu Feng,Rui Wang,Jianzhong Zhu,Ruohan Lou,Jia Liu,Yang Ye,Ligen Lin
DOI: https://doi.org/10.1111/bph.15979
IF: 7.3
2022-11-04
British Journal of Pharmacology
Abstract:Background and Purpose Pharmacological intervention to induce browning of white adipose tissue provides a promising anti‐obesity therapy. The fruits of Garcinia cambogia (Clusiaceae) have been widely applied to manage body weight, however the chemical principles remain unclear. The current study aims to discover browning inducers from the fruits of G. cambogia and investigate the underlying mechanisms. Experimental Approach The bioactivity‐based molecular networking and Oil‐red O staining on 3T3‐L1 and C3H10T1/2 adipocytes were applied for guided isolation. High‐fat diet‐induced obese mice were recruited to evaluate the anti‐obesity activity. Key Results The bioactivity‐based molecular networking‐guided isolation yielded several polycyclic polyprenylated acylphloroglucinols from the fruits of G. cambogia with lipid lowering effect on adipocytes, including guttiferone J (GOJ), garcinol and 14‐deoxygarcinol. As the most potent one, GOJ (10 μM) reduced lipid accumulation by 70% and 76% in 3T3‐L1 and C3H10T1/2 adipocytes, respectively. Furthermore, GOJ (2.5–10 μM) increased the expression of the deacetylase Sirtuin 3 (SIRT3) and activated it, which, in turn, reduced the acetylation level of PPARγ coactivator‐1α to boost mitochondrial biogenesis, and promoted uncoupling protein 1 expression to enhance thermogenesis, resulting in browning of adipocytes. In high‐fat diet‐induced‐obese mice, GOJ (10 and 20 mg·kg‐1·day‐1 for 12 weeks) protected against adiposity, hyperlipidemia, insulin resistance and liver lipotoxicity, through boosting SIRT3‐mediated browning of inguinal adipose tissue. Conclusions and Implications GOJ represents a new scaffold of thermogenic inducer, which is responsible for the anti‐obesity property of G. cambogia and can be further developed as a candidate for treating obesity and its related disorders.
pharmacology & pharmacy
What problem does this paper attempt to address?